Business
SimBioSys and Ricoh 3D for Healthcare announce strategic alliance expanding access to TumorSight™ Viz for breast cancer surgery
SimBioSys®, a clinical AI company leveraging spatial biophysics to drive precision in breast cancer treatment, and Ricoh 3D for Healthcare, LLC, a wholly owned subsidiary of Ricoh USA, Inc. ("Ricoh") focused on delivering FDA-cleared, patient-specific medical devices through centralized and point-of-care manufacturing, today announced a strategic, non-exclusive distribution agreement to broaden market access to TumorSight™ Viz—SimBioSys' FDA-cleared 3D surgical visualization platform for breast
About this update from Ricoh Company, Ltd.
[{"type":"text","content":"Commercial partnership expected to accelerate adoption of SimBioSys' AI-powered surgical visualization platform following recent FDA clearance of TumorSight Viz 1.3","length":168,"tagName":"p","attribs":{}},{"type":"text","content":"CHICAGO and EXTON, Pa., Aug. 27, 2025 /PRNewswire/ -- SimBioSys®, a clinical AI company leveraging spatial biophysics to drive precision in breast cancer treatment, and Ricoh 3D for Healthcare, LLC, a wholly owned subsidiary of Ricoh USA, Inc. ("Ricoh") focused on delivering FDA-cleared, patient-specific medical devices through centralized and point-of-care manufacturing, today announced a strategic, non-exclusive distribution agreement to broaden market access to TumorSight™ Viz—SimBioSys' FDA-cleared 3D surgical visualization platform for breast cancer.","length":580,"tagName":"p"},{"type":"image","alt":"An MRI image seen using the TumorSight™ Viz 3D visualization platform.","displaySize":"","headline":null,"caption":"An MRI image seen using the TumorSight™ Viz 3D visualization platform.","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":215,"url":"https://media.zenfs.com/en/prnewswire.com/33fd070fe592c429bfc29e72c39e53e8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Q2VlUvnYH1mADI3G5GftLg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM3OTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/33fd070fe592c429bfc29e72c39e53e8","width":400,"height":215}},"href":"https://mma.prnewswire.com/media/2758578/TumorSight_Viz.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"TumorSight™ Viz converts standard breast MRI into intuitive, 3D visualizations that reveal tumor size, location, and spatial orientation relative to surrounding anatomy—supporting more informed and individualized surgical decision-making. TumorSight Viz 1.3 offers industry-leading segmentation accuracy, delivers case results in minutes, and integrates with hospital PACS to streamline planning and coordination.1","length":414,"tagName":"p"},{"type":"text","content":"This partnership follows the recent FDA 510(k) clearance of TumorSight Viz 1.3 and reflects a shared commitment to bringing next-generation digital health technologies to market at scale. By combining SimBioSys' category-defining software with Ricoh's deep expertise in healthcare services,...